Effectiveness of Voxelotor for Treating Sickle Cell Disease
Latest Information Update: 18 Jan 2023
At a glance
- Drugs Voxelotor (Primary)
- Indications Sickle cell anaemia
- Focus Therapeutic Use
- 13 Dec 2022 Results (n=4023) evaluating rates of transfusions, vaso-occlusive crises, and hospitalizations among patients with SCD, including pediatric patients, presented at the 64th American Society of Hematology Annual Meeting and Exposition.
- 14 Dec 2021 Results (As of March 2021, n=2695 )presented at the 63rd American Society of Hematology Annual Meeting and Exposition
- 12 Dec 2021 Results (n=3128) presented in Global Blood Therapeutics media released.